Gene · 824
Papers2,355
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,355
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Calpain-mediated proteolysis of vimentin filaments is augmented in giant axonal neuropathy fibroblasts exposed to hypotonic stress. | Front Cell Dev Biol | 2022 | 36393840 | PubTator, text mining | PubMed |
| Calpain-mediated proteolysis as driver and modulator of polyglutamine toxicity. | Front Mol Neurosci | 2022 | 36385755 | PubTator, text mining | PubMed |
| Comparative Transcriptomics and Proteomics of Cancer Cell Lines Cultivated by Physiological and Commercial Media. | Biomolecules | 2022 | 36358924 | PubTator, text mining | PubMed |
| RUNX2 Mediates Renal Cell Carcinoma Invasion through Calpain2. | Biol Pharm Bull | 2022 | 36328501 | PubTator, text mining | PubMed |
| Transcription factor NRF2 as potential therapeutic target for preventing muscle wasting in aging chronic kidney disease patients. | J Nephrol | 2022 | 36322291 | PubTator, text mining | PubMed |
| Cancer cells can be killed mechanically or with combinations of cytoskeletal inhibitors. | Front Pharmacol | 2022 | 36299893 | PubTator, text mining | PubMed |
| Activation of Host Cellular Signaling and Mechanism of Enterovirus 71 Viral Proteins Associated with Hand, Foot and Mouth Disease. | Viruses | 2022 | 36298746 | PubTator, text mining | PubMed |
| Label-Free Quantitative Proteomics Analysis of Adriamycin Selected Multidrug Resistant Human Lung Cancer Cells. | Biomolecules | 2022 | 36291610 | PubTator, text mining | PubMed |
| Hemoxygenase-1 Promotes Head and Neck Cancer Cell Viability. | Antioxidants (Basel) | 2022 | 36290800 | PubTator, text mining | PubMed |
| Classical Angiogenic Signaling Pathways and Novel Anti-Angiogenic Strategies for Colorectal Cancer. | Curr Issues Mol Biol | 2022 | 36286020 | PubTator, text mining | PubMed |
| Narrative Review: Glucocorticoids in Alcoholic Hepatitis-Benefits, Side Effects, and Mechanisms. | J Xenobiot | 2022 | 36278756 | PubTator, text mining | PubMed |
| How does plasticity of migration help tumor cells to avoid treatment: Cytoskeletal regulators and potential markers. | Front Pharmacol | 2022 | 36278174 | PubTator, text mining | PubMed |
| Innate immune checkpoint inhibitor resistance is associated with melanoma sub-types exhibiting invasive and de-differentiated gene expression signatures. | Front Immunol | 2022 | 36248850 | PubTator, text mining | PubMed |
| Thirteenth Annual ENBDC Workshop: Methods in Mammary Gland Biology and Breast Cancer. | J Mammary Gland Biol Neoplasia | 2022 | 36242657 | PubTator, text mining | PubMed |
| Weakly activated core neuroinflammation pathways were identified as a central signaling mechanism contributing to the chronic neurodegeneration in Alzheimer's disease. | Front Aging Neurosci | 2022 | 36238934 | PubTator, text mining | PubMed |
| NSMCE2, a novel super-enhancer-regulated gene, is linked to poor prognosis and therapy resistance in breast cancer. | BMC Cancer | 2022 | 36224576 | PubTator, text mining | PubMed |
Association between inflammatory cytokines in the aqueous humor and hyperreflective foci on optical coherence tomography in patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. | Front Med (Lausanne) | 2022 | 36213652 | PubTator, text mining | PubMed |
| TRPC6 mediates high glucose-induced mitochondrial fission through activation of CDK5 in cultured human podocytes. | Front Physiol | 2022 | 36213244 | PubTator, text mining | PubMed |
| An eleven autophagy-related genes-based prognostic signature for endometrial carcinoma. | J Egypt Natl Canc Inst | 2022 | 36210389 | PubTator, text mining | PubMed |
| Neoepitope fragments as biomarkers for different phenotypes of intervertebral disc degeneration. | JOR Spine | 2022 | 36203866 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/824/papers?page=16